Solara Active Pharma Board Meeting on July 23, 2026

Solara Active Pharma Sciences Ltd has announced that its Board of Directors will convene on July 23, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter ended June 30, 2026, encompassing both standalone and consolidated statements. Additionally, the company has informed that its trading window for designated persons will be closed from July 1, 2026, until 48 hours after the announcement of these financial results, in compliance with SEBI's Insider Trading Regulations. The company's website will also host this information.